 |
PDBsum entry 6bb4
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
6bb4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Fab/epitope complex of mouse monoclonal antibody c5.2 targeting a phospho-tau epitope.
|
|
Structure:
|
 |
Mouse monoclonal antibody c5.2 fab light chain. Chain: l, m, n. Mouse monoclonal antibody c5.2 fab heavy chain. Chain: h, i, j. Microtubule-associated protein tau. Chain: p, q, r. Synonym: neurofibrillary tangle protein,paired helical filament-tau, phf-tau. Engineered: yes
|
|
Source:
|
 |
Mus musculus. Organism_taxid: 10090. Synthetic: yes. Homo sapiens. Human. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.218
|
R-free:
|
0.270
|
|
|
Authors:
|
 |
J.E.Chukwu,X.-P.Kong
|
|
Key ref:
|
 |
J.E.Chukwu
et al.
(2018).
Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.
Sci Rep,
8,
6209.
PubMed id:
|
 |
|
Date:
|
 |
|
16-Oct-17
|
Release date:
|
02-May-18
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Sci Rep
8:6209
(2018)
|
|
PubMed id:
|
|
|
|
|
| |
|
Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein.
|
|
J.E.Chukwu,
J.T.Pedersen,
L.Ã.˜.Pedersen,
C.Volbracht,
E.M.Sigurdsson,
X.P.Kong.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Tau antibodies have shown therapeutic potential for Alzheimer's disease and
several are in clinical trials. As a microtubule-associated protein, tau relies
on dynamic phosphorylation for its normal functions. In tauopathies, it becomes
hyperphosphorylated and aggregates into toxic assemblies, which collectively
lead to neurodegeneration. Of the phospho-epitopes, the region around Ser396 has
received particular attention because of its prominence and stability in
tauopathies. Here we report the first structure of a monoclonal tau antibody in
complex with the pathologically important phospho-Ser396 residue. Its binding
region reveals tau residues Tyr394 to phospho-Ser396 stabilized in a β-strand
conformation that is coordinated by a phospho-specific antigen binding site.
These details highlight a molecular switch that defines this prominent
conformation of tau and ways to target it. Overall, the structure of the
antibody-antigen complex clarifies why certain phosphorylation sites in tau are
more closely linked to neurodegeneration than others.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|